Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028
Triton’s report has concluded the stem
cell market in North America to expect growth at a CAGR of 7.41% during the forecast
period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market
are:
•
United States
•
Canada
The rising R&D spending to develop
innovative stem cell therapies to treat chronic and rare conditions is
anticipated to motivate the stem cell market’s progress in the United States.
Additionally, the country’s healthcare infrastructure is well-developed compared
to most developed nations, with a high number of products in line for stem cell
therapies. This further adds to the studied market’s progress. Moreover, the
growing number of cancer cases opens new avenues for market players, leading to
a rise in R&D activities among players to launch new stem cell therapies.
Furthermore, the pandemic outbreak has
increased research activities to treat the spread of the virus. Here, stem cell
therapy can be termed as a promising approach in COVID-19 treatment. However,
its research is still in its initial stage. For instance, Lineage Cell
Therapeutics obtained significant funding from the California Institute for
Regenerative Medicine to support VAC’s use, allogeneic dendritic cell therapy
to develop a potential vaccine to limit the spread of the virus. Such actions
indicate a robust growth of the stem cell market in the upcoming years.
Likewise, Canada is among the leading
countries in stem cell research, with researchers implementing stem cell
therapy in the healthcare sector to treat several conditions. There is a high
incidence rate of heart diseases in the country, which enhances the need for
the development of innovative stem cell therapies for treating heart
conditions. Additionally, the rising focus on stem cell research is also likely
to motivate the growth of the stem cell market across Canada in the near
future.
Cytori Therapeutics is a pharmaceutical
company involved in the development of medical devices that permit the
therapeutic usage of regenerative cells and adult stem found with the adipose
(fat) tissue. It provides its products to physicians and patients at
point-of-service. Moreover, the firm’s commercial activities are mainly
concentrated on cell banking, cosmetic & reconstructive surgery, and distribution
of research tools. It has its headquarter in Texas, the United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA STEM CELL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON STEM CELL MARKET
2.3. KEY
IMPACT ANALYSIS
2.4. INDUSTRY
COMPONENTS
2.5. LEGAL,
POLICY, & REGULATORY FRAMEWORK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
INSIGHTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AWARENESS ABOUT UMBILICAL CORD STEM CELLS
2.9.2. SURGE
IN STEM CELL RESEARCH AND DEVELOPMENT
2.9.3. RISING
DEMAND FOR REGENERATIVE MEDICINE
2.10. MARKET
RESTRAINTS
2.10.1. ETHICAL
CONCERNS ASSOCIATED WITH STEM CELLS
2.10.2. HIGH
COST OF STEM CELL PROCEDURES
2.10.3. STRINGENT
REGULATIONS IN TERMS OF STEM CELL THERAPY
2.11. MARKET
OPPORTUNITIES
2.11.1. ADVANCEMENT
IN TECHNOLOGY
2.11.2. RISK
OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS
3. NORTH
AMERICA STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION
3.1. NEUROLOGICAL
DISORDERS
3.2. ONCOLOGY
DISORDERS
3.3. DIABETES
3.4. INJURIES
AND WOUNDS
3.5. ORTHOPEDIC
TREATMENTS
3.6. CARDIOVASCULAR
DISORDERS
3.7. OTHER
THERAPEUTIC APPLICATIONS
4. NORTH
AMERICA STEM CELL MARKET OUTLOOK - BY TECHNOLOGY
4.1. CRYOPRESERVATION
4.2. ACQUISITION
4.2.1. STEM
CELL APHERESIS
4.2.2. STEM
CELL BONE MARROW MARKET
4.2.3. STEM
CELL UMBILICAL CORD
4.3. EXPANSION
AND SUB-CULTURE
4.4. PRODUCTION
4.4.1. STEM
CELL CULTURE
4.4.2. THERAPEUTIC
CLONING
4.4.3. IVF
5. NORTH
AMERICA STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE
5.1. ALLOGENEIC
STEM CELL THERAPY
5.2. AUTOLOGIC
STEM CELL THERAPY
5.3. SYNGENEIC
STEM CELL THERAPY
6. NORTH
AMERICA STEM CELL MARKET OUTLOOK - BY PRODUCT
6.1. ADULT
STEM CELL
6.1.1. HEMATOPOIETIC
STEM CELL
6.1.2. NEURAL
STEM CELL
6.1.3. UMBILICAL
CORD STEM CELL
6.1.4. MESENCHYMAL
STEM CELL
6.1.5. DENTAL
STEM CELL
6.2. HUMAN
EMBRYONIC STEM CELL
6.3. PLURIPOTENT
6.4. MOUSE/RAT
NEURAL
7. NORTH
AMERICA STEM CELL MARKET OUTLOOK - BY APPLICATION
7.1. REGENERATIVE
MEDICINE
7.2. DRUG
DISCOVERY AND DEVELOPMENT
8. GEOGRAPHICAL
ANALYSIS - NORTH AMERICA
8.1. COUNTRY
ANALYSIS
8.1.1. UNITED
STATES
8.1.2. CANADA
9. COMPANY
PROFILES
9.1. CORNING
INC
9.2. STEMCELL
TECHNOLOGIES
9.3. STRYKER
CORPORATION
9.4. BECTON
DICKINSON AND COMPANY (BD)
9.5. CYTORI
THERAPEUTICS
9.6. QIAGEN
NV
9.7. GE
HEALTHCARE
9.8. TAKARA
HOLDINGS
9.9. SMITH
& NEPHEW PLC
9.10. INTERNATIONAL
STEM CELL CORP
9.11. MILTENYI
BIOTEC
9.12. MERCK
KGAA (SIGMA ALDRICH)
9.13. THERMO
FISHER SCIENTIFIC INC
9.14. ALLCELLS
LLC
9.15. PLURISTEM
THERAPEUTICS INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 NORTH AMERICA STEM CELL MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 NORTH AMERICA STEM CELL MARKET, BY
THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 4 NORTH AMERICA STEM CELL MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 5 NORTH AMERICA ACQUISITION MARKET, BY
TYPE, 2021-2028 (IN $ MILLION)
TABLE 6 NORTH AMERICA PRODUCTION MARKET, BY
TYPE, 2021-2028 (IN $ MILLION)
TABLE 7 NORTH AMERICA STEM CELL MARKET, BY
TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 8 NORTH AMERICA STEM CELL MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 9 NORTH AMERICA ADULT STEM CELL MARKET, BY
TYPE, 2021-2028 (IN $ MILLION)
TABLE 10 NORTH AMERICA STEM CELL MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 11 NORTH AMERICA STEM CELL MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1 NORTH AMERICA STEM CELL MARKET 2021-2028
(IN $ MILLION)
FIGURE 2 NORTH AMERICA STEM CELL MARKET, BY
NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 3 NORTH AMERICA STEM CELL MARKET, BY
ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 4 NORTH AMERICA STEM CELL MARKET, BY
DIABETES, 2021-2028 (IN $ MILLION)
FIGURE 5 NORTH AMERICA STEM CELL MARKET, BY
INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)
FIGURE 6 NORTH AMERICA STEM CELL MARKET, BY
ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7 NORTH AMERICA STEM CELL MARKET, BY
CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 8 NORTH AMERICA STEM CELL MARKET, BY OTHER
THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 9 NORTH AMERICA STEM CELL MARKET, BY
CRYOPRESERVATION, 2021-2028 (IN $ MILLION)
FIGURE 10 NORTH AMERICA STEM CELL MARKET, BY
ACQUISITION, 2021-2028 (IN $ MILLION)
FIGURE 11 NORTH AMERICA STEM CELL MARKET, BY STEM CELL
APHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 12 NORTH AMERICA STEM CELL MARKET, BY STEM CELL
BONE MARROW MARKET, 2021-2028 (IN $ MILLION)
FIGURE 13 NORTH AMERICA STEM CELL MARKET, BY STEM CELL
UMBILICAL CORD, 2021-2028 (IN $ MILLION)
FIGURE 14 NORTH AMERICA STEM CELL MARKET, BY EXPANSION
AND SUB-CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 15 NORTH AMERICA STEM CELL MARKET, BY
PRODUCTION, 2021-2028 (IN $ MILLION)
FIGURE 16 NORTH AMERICA STEM CELL MARKET, BY STEM CELL
CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 17 NORTH AMERICA STEM CELL MARKET, BY
THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)
FIGURE 18 NORTH AMERICA STEM CELL MARKET, BY IVF,
2021-2028 (IN $ MILLION)
FIGURE 19 NORTH AMERICA STEM CELL MARKET, BY ALLOGENEIC
STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 20 NORTH AMERICA STEM CELL MARKET, BY AUTOLOGIC
STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 21 NORTH AMERICA STEM CELL MARKET, BY SYNGENEIC
STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 22 NORTH AMERICA STEM CELL MARKET, BY ADULT STEM
CELL, 2021-2028 (IN $ MILLION)
FIGURE 23 NORTH AMERICA STEM CELL MARKET, BY
HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 24 NORTH AMERICA STEM CELL MARKET, BY NEURAL
STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 25 NORTH AMERICA STEM CELL MARKET, BY UMBILICAL
CORD STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 26 NORTH AMERICA STEM CELL MARKET, BY
MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 27 NORTH AMERICA STEM CELL MARKET, BY DENTAL
STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 28 NORTH AMERICA STEM CELL MARKET, BY HUMAN
EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 29 NORTH AMERICA STEM CELL MARKET, BY
PLURIPOTENT, 2021-2028 (IN $ MILLION)
FIGURE 30 NORTH AMERICA STEM CELL MARKET, BY MOUSE/RAT
NEURAL, 2021-2028 (IN $ MILLION)
FIGURE 31 NORTH AMERICA STEM CELL MARKET, BY
REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32 NORTH AMERICA STEM CELL MARKET, BY DRUG
DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 33 UNITED STATES STEM CELL MARKET 2021-2028 (IN
$ MILLION)
FIGURE 34 CANADA STEM CELL MARKET 2021-2028 (IN $
MILLION)